Mitochondrial genome variability and metabolic alterations reveal new biomarkers of resistance in testicular germ cell tumors

Abstract

Aim: Mutations in the mitochondrial (mt) genome contribute to metabolic dysfunction and their accumulation relates to disease progression and resistance development in cancer cells. This study explores the mutational status of the mt genome of cisplatin-resistant vs. -sensitive testicular germ cell tumor (TGCT) cells and explores its association with their respiration parameters, expression of respiratory genes, and preferences for metabolic pathways to reveal new markers of therapy resistance in TGCTs.

Methods: Using Illumina sequencing with Twist Enrichment Panel, the mutations of mt genomes of sensitive 2102EP, H12.1, NTERA-2, T-cam and resistant 2102EP Cis, H12.1 ODM, 1411HP, 1777NRpmet, NTERA-2 Cis and T-cam Cis cell lines were identified. The mt respiration of the cells was assessed using high-resolution respirometry method (O2k-respirometer Oroboros) and the differential expression profiles of mt respiratory genes were determined using RT-qPCR. Associated preferences for metabolic pathways were compared using Glycolysis/OXPHOS assay.

Results: In resistant TGCT cells, new mutations in mt genes MT-ND1-6, MT-RNR, MT-CO1-3, MT-ATP6, and MT-CYB were recognized. The respiratory rates of the 1777NRpmet cell line were the highest, while those of the 1411HP line the lowest; rates of the control and all other TGCT cell lines fell between these two lines. The statistically significant differences in gene expression of the respiratory genes were recorded only in NTERA-2 Cis and T-cam Cis cell lines. Sensitive cell lines NTERA-2 and 2102EP preferred oxidative phosphorylation (OXPHOS), while glycolysis was typical for resistant NTERA-2 Cis, 2102EP Cis and 1411HP cell lines. Metastatic 1777NRpmet cells seem to utilize both. An isogenic pair of cell lines H12.1 and H12.1ODM showed the opposite dependence, sensitive H12.1 preferring glycolysis, while resistant H12.1ODM OXPHOS.

Conclusion: In summary, our study identified new mutations in mt genes of resistant TGCT cell lines that are associated with different mt respiration parameters, gene expression patterns and preferences for metabolic pathways, providing potential novel molecular biomarkers that distinguish the resistant TGCT phenotype or specify its histological classification.

Keywords

Testicular cancer / chemoresistance / mitochondria / mtDNA mutation / OXPHOS / glycolysis

References

[1] Ottaviano M,Rescigno P.The enigmatic role of TP53 in germ cell tumours: are we missing something?.Int J Mol Sci2021;22:7160 PMCID:PMC8267694

[2] Adra N.Testicular cancer update.Clin Adv Hematol Oncol2017;15:386-96

[3] Romano FJ,Conteduca V.Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review.Oncotarget2016;7:85641-9 PMCID:PMC5356765

[4] Zhang CJ,Shen KJ,Xu DF.Characterization of progression-related alternative splicing events in testicular germ cell tumors.Asian J Androl2021;23:259-65 PMCID:PMC8152425

[5] Gogvadze V,Zhivotovsky B.Mitochondria in cancer cells: what is so special about them?.Trends Cell Biol2008;18:165-73

[6] Ma K,Li W,Zhu Y.Mitophagy, mitochondrial homeostasis, and cell fate.Front Cell Dev Biol2020;8:467 PMCID:PMC7326955

[7] Protasoni M.Mitochondrial structure and bioenergetics in normal and disease conditions.Int J Mol Sci2021;22:586 PMCID:PMC7827222

[8] Bestwick ML.Accessorizing the human mitochondrial transcription machinery.Trends Biochem Sci2013;38:283-91 PMCID:PMC3698603

[9] Liu W,Luo J,Luo Z.Genetic polymorphisms and platinum-based chemotherapy-induced toxicities in patients with lung cancer: a systematic review and meta-analysis.Front Oncol2019;9:1573 PMCID:PMC7090160

[10] Gammage PA.Mitochondrial DNA: the overlooked oncogenome?.BMC Biol2019;17:53 PMCID:PMC6615100

[11] Guzy RD.Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia.Exp Physiol2006;91:807-19

[12] Roška J,Hurbanová L.Differential gene expression in cisplatin-resistant and -sensitive testicular germ cell tumor cell lines.Oncotarget2020;11:4735-53 PMCID:PMC7771712

[13] Mueller T,Luetzkendorf J,Simon H.Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.Tumour Biol2006;27:71-83

[14] Balin SJ.The rate of mutation of a single gene.Nucleic Acids Res2010;38:1575-82 PMCID:PMC2836558

[15] Pesta D.High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle.Methods Mol Biol2012;810:25-58

[16] MitoPedia. SUIT-008 O2 ce-pce D025. Available from: https://wiki.oroboros.at/index.php/SUIT-008_O2_ce-pce_D025. [Last accessed on 12 Dec 2024].

[17] Eigentler A, Draxl A, Wiethüchter A, Kuznetsov AV, Lassing B, Gnaiger E. Laboratory protocol: citrate synthase a mitochondrial marker enzyme. MiPNet 2015;17:1-11. Available from: https://wiki.oroboros.at/images/archive/4/40/20200417143232%21MiPNet17.04_CitrateSynthase.pdf. [Last accessed on 12 Dec 2024].

[18] Batool A,Wu XN,Liu YX.Testicular germ cell tumor: a comprehensive review.Cell Mol Life Sci2019;76:1713-27 PMCID:PMC11105513

[19] Howitt BE.Tumors of the testis: morphologic features and molecular alterations.Surg Pathol Clin2015;8:687-716

[20] Marullo R,Degtyareva N.Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions.PLoS One2013;8:e81162 PMCID:PMC3834214

[21] Taylor-Weiner A,O'Donnell E.Genomic evolution and chemoresistance in germ-cell tumours.Nature2016;540:114-8 PMCID:PMC5553306

[22] Koshikawa N,Hayashi JI,Takenaga K.Association of predicted pathogenic mutations in mitochondrial ND genes with distant metastasis in NSCLC and colon cancer.Sci Rep2017;7:15535 PMCID:PMC5686070

[23] Zeviani M.Mitochondrial disorders.Brain2004;127:2153-72

[24] Simonnet H,Pfeiffer K.Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma.Carcinogenesis2002;23:759-68

[25] Malfatti E,Invernizzi F.Novel mutations of ND genes in complex I deficiency associated with mitochondrial encephalopathy.Brain2007;130:1894-904

[26] Moslemi AR,Tulinius M,Holme E.Progressive encephalopathy and complex I deficiency associated with mutations in MTND1.Neuropediatrics2008;39:24-8

[27] Kösel S,Mautsch U.Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease.Neurogenetics1998;1:197-204

[28] Vives-Bauza C,Manfredi G.Sequence analysis of the entire mitochondrial genome in Parkinson’s disease.Biochem Biophys Res Commun2002;290:1593-601

[29] van der Walt JM,Martin ER.Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease.Am J Hum Genet2003;72:804-11 PMCID:PMC1180345

[30] Coskun PE,Wallace DC.Alzheimer’s brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication.Proc Natl Acad Sci U S A2004;101:10726-31 PMCID:PMC490002

[31] Alharbi MA,Khalaf NB.Four novel mutations in the mitochondrial ND4 gene of complex I in patients with multiple sclerosis.Biomed Rep2019;11:257-68 PMCID:PMC6873451

[32] Yeh JJ,van Orsouw NJ.Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours.Oncogene2000;19:2060-6

[33] Linnartz B,Zanssen S.Comprehensive scanning of somatic mitochondrial DNA alterations in acute leukemia developing from myelodysplastic syndromes.Cancer Res2004;64:1966-71

[34] Brandon M,Wallace DC.Mitochondrial mutations in cancer.Oncogene2006;25:4647-62

[35] Kirches E,Warich-Kirches M.High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples.Int J Cancer2001;93:534-8

[36] Xu B,Tuttle RM.Outcome and molecular characteristics of non-invasive encapsulated follicular variant of papillary thyroid carcinoma with oncocytic features.Endocrine2019;64:97-108 PMCID:PMC6657696

[37] Pang LJ,Liang XM,Zeng YX.Mitochondrial DNA somatic mutations are frequent in nasopharyngeal carcinoma.Cancer Biol Ther2008;7:198-207

[38] Mbaye F,Fall M.Genetic diversity of breast cancer in senegalese women: new insight from somatic mutations.J Health Sci2014;4.2:25-33

[39] Máximo V,Lima J,Sobrinho-Simões M.Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.Am J Pathol2002;160:1857-65 PMCID:PMC1850872

[40] Cardaioli E,Hayek G,Federico A.Studies on mitochondrial pathogenesis of Rett syndrome: ultrastructural data from skin and muscle biopsies and mutational analysis at mtDNA nucleotides 10463 and 2835.J Submicrosc Cytol Pathol1999;31:301-4

[41] Abril J,González L.Altered expression of 12S/MT-RNR1, MT-CO2/COX2, and MT-ATP6 mitochondrial genes in prostate cancer.Prostate2008;68:1086-96

[42] Bragoszewski P,Bartnik E,Ostrowski J.Limited clinical relevance of mitochondrial DNA mutation and gene expression analyses in ovarian cancer.BMC Cancer2008;8:292 PMCID:PMC2571110

[43] Lin YH,Lim SN,Yeh CT.Impact of an MT-RNR1 gene polymorphism on hepatocellular carcinoma progression and clinical characteristics.Int J Mol Sci2021;22:1119 PMCID:PMC7865300

[44] Ghaffarpour M,Fereidooni F,Moazami N.The mitochondrial ATPase6 gene is more susceptible to mutation than the ATPase8 gene in breast cancer patients.Cancer Cell Int2014;14:21 PMCID:PMC3942513

[45] Musumeci O,Shanske S.Intragenic inversion of mtDNA: a new type of pathogenic mutation in a patient with mitochondrial myopathy.Am J Hum Genet2000;66:1900-4 PMCID:PMC1378040

[46] Moindjie H,Nahmias C.Mitochondrial metabolism in carcinogenesis and cancer therapy.Cancers2021;13:3311 PMCID:PMC8269082

[47] Tan AS,Berridge MV.The role of mitochondrial electron transport in tumorigenesis and metastasis.Biochim Biophys Acta2014;1840:1454-63

[48] Gasparre G,Lenaz G.Relevance of mitochondrial genetics and metabolism in cancer development.Cold Spring Harb Perspect Biol2013;5:a011411 PMCID:PMC3552507

[49] Badrinath N.Mitochondria in cancer: in the aspects of tumorigenesis and targeted therapy.Carcinogenesis2018;39:1419-30

[50] Mendiratta G,Aziz M,Tong M.Cancer gene mutation frequencies for the U.S. population.Nat Commun2021;12:5961 PMCID:PMC8514428

[51] Warburg O,Negelein E.The metabolism of tumors in the body.J Gen Physiol1927;8:519-30 PMCID:PMC2140820

[52] Weinhouse S.The Warburg hypothesis fifty years later.Z Krebsforsch Klin Onkol Cancer Res Clin Oncol1976;87:115-26

[53] Goto M,Shikami M.Importance of glutamine metabolism in leukemia cells by energy production through TCA cycle and by redox homeostasis.Cancer Invest2014;32:241-7

[54] Faubert B,DeBerardinis RJ.Metabolic reprogramming and cancer progression.Science2020;368:eaaw5473 PMCID:PMC7227780

[55] Cannino G,Masgras I,Rasola A.Metabolic plasticity of tumor cell mitochondria.Front Oncol2018;8:333 PMCID:PMC6117394

[56] Andreyev AY,Starkov AA.Mitochondrial metabolism of reactive oxygen species.Biochemistry2005;70:200-14

[57] Sullivan LB,Hosios AM,Freinkman E.Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells.Cell2015;162:552-63 PMCID:PMC4522278